Fetal blood group genotyping

Transfusion

Volumn 47, Issue SUPPL. 1, 2007, Pages

  Denomme, Gregory A ^a   Fernandes, Bernard J ^b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIGEN;

ALLELE; ALLOIMMUNITY; ANTIGEN EXPRESSION; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; CONFERENCE PAPER; DNA EXTRACTION; DNA MICROARRAY; FETUS BLOOD; FETUS RISK; GENOTYPE; HEMOLYTIC ANEMIA; HETEROZYGOSITY; HUMAN; IMMUNOPHENOTYPING; INHERITANCE; MATERNAL PLASMA; ZYGOSITY;

ALLELES; BLOOD GROUP ANTIGENS; BLOOD SPECIMEN COLLECTION; DNA; ERYTHROBLASTOSIS, FETAL; FEMALE; FETAL BLOOD; GENOTYPE; HUMANS; INHERITANCE PATTERNS; MOLECULAR DIAGNOSTIC TECHNIQUES; PATERNITY; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 34250657944     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01313.x     Document Type: Conference Paper

References (42)

1. Levine P, Stetson RE. An unusual case of intra-group agglutination. JAMA 1939 113 : 126 7.
2. Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997 21 : 39 44.
3. Pollack W, Gorman JG, Freda VJ, et al. Results of clinical trials of RhoGAM in women. Transfusion 1968 8 : 151 3.
4. Death by cause, chapter XVI: certain conditions originating in the perinatal period. Statistics Canada, 2004. Available at: http://www.statcan.ca/ english/freepub/84F0209XIE/2004000/related.htm
5. Mourant AE. The distribution of human blood groups and other polymorphisms, 2nd ed. London : Oxford University Press, 1976.
6. Flegel WA, Wagner FF. Molecular genetics of RH. Vox Sang 2000 78 (Suppl. 2 109 15.
7. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000 95 : 3662 8.
8. Grootkerk-Tax MG, Maaskant-van Wijk PA, van Drunen J, et al. The highly variable RH locus in nonwhite persons hampers RHD zygosity determination but yields more insight into RH-related evolutionary events. Transfusion 2005 45 : 327 37.
9. Matheson KA, Denomme GA. Novel 3′Rhesus box sequences confound RHD zygosity assignment. Transfusion 2002 42 : 645 50.
10. Perco P, Shao CP, Mayr WR, et al. Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type. Transfusion 2003 43 : 335 9.
11. Wagner FF, Moulds JM, Flegel WA. Genetic mechanisms of Rhesus box variation. Transfusion 2005 45 : 338 44.
12. Chiu RW, Murphy MF, Fidler C, et al. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin Chem 2001 47 : 667 72.
13. Li Y, Zimmermann B, Zhong XY, et al. Determination of RHD zygosity using real-time quantitative PCR. Swiss Med Wkly 2003 133 : 442 5.
14. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000 95 : 12 8.
15. Faas BH, Beckers EA, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997 37 : 38 44.
16. Weiner CP. Use of cordocentesis in fetal hemolytic disease and autoimmune thrombocytopenia. Am J Obstet Gynecol 1990 162 : 1126 8.
17. Weiner CP, Okamura K. Diagnostic fetal blood sampling-technique related losses. Fetal Diagn Ther 1996 11 : 169 75.
18. Scott R. Limb abnormalities after chorionic villus sampling. Lancet 1991 337 : 1038 9.
19. Griffith-Jones MD, Miller D, Lilford RJ, et al. Detection of fetal DNA in trans-cervical swabs from first trimester pregnancies by gene amplification: a new route to prenatal diagnosis? Br J Obstet Gynaecol 1992 99 : 508 11.
20. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 2004 18 : 877 91.
21. Denomme GA, Waye JS, Burrows RF, et al. The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis. Br J Haematol 1995 91 : 742 6.
22. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997 350 : 485 7.
23. Grootkerk-Tax MG, Soussan AA, de Haas M, et al. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006 46 : 2142 8.
24. Minon JM, Senterre JM, Schaaps JP, et al. An unusual false-positive fetal RHD typing result using DNA derived from maternal plasma from a solid organ transplant recipient. Transfusion 2006 46 : 1454 5.
25. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996 93 : 705 8.
26. Ariga H, Ohto H, Busch MP, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001 41 : 1524 30.
27. Bennett PR, Warwick R, Letsky E, et al. Determination of fetal RhD type by DNA amplification from fetal skin following massive fetomaternal haemorrhage and intrauterine fetal death. Br J Obstet Gynaecol 1994 101 : 636 7.
28. Wolter LC, Hyland CA, Saul A. Rhesus D genotyping using polymerase chain reaction. Blood 1993 82 : 1682 3.
29. Denomme GA, Akoury H, Sermer M, et al. RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype. Prenat Diagn 1999 19 : 424 7.
30. Daniels G, van der Schoot CE, Olsson ML. Report of the First International Workshop on molecular blood group genotyping. Vox Sang 2005 88 : 136 42.
31. Maaskant-van Wijk PA, Faas BH, de Ruijter JA, et al. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion 1998 38 : 1015 21.
32. Ekman GC, Billingsly R, Hessner MJ. Rh genotyping: avoiding false-negative and false-positive results among individuals of African ancestry. Am J Hematol 2002 69 : 34 40.
33. Oepkes D, Seaward PG, Vandenbussche FP, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006 355 : 156 64.
34. Lo, YM, Hjelm, NM, Fidler, C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998 339 : 1734 8.
35. Finning KM, Martin PG, Soothill PW, et al. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002 42 : 1079 85.
36. Turner MJ, Martin CM, O'Leary JJ. Detection of fetal Rhesus D gene in whole blood of women booking for routine antenatal care. Eur J Obstet Gynecol Reprod Biol 2003 108 : 29 32.
37. Randen I, Hauge R, Kjeldsen-Kragh J, et al. Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 2003 85 : 300 6.
38. Rouillac-Le Sciellour C, Puillandre P, Gillot R, et al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Mol Diagn 2004 8 : 23 31.
39. Gautier E, Benachi A, Giovangrandi Y, et al. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 2005 192 : 666 9.
40. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004 1022 : 119 23.
41. van der Schoot CE, Soussan AA, Koelewijn J, et al. Non-invasive antenatal RHD typing. Transfus Clin Biol 2006 13 : 53 7.
42. Zhou L, Thorson JA, Nugent C, et al. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am J Obstet Gynecol 2005 193 : 1966 71.